MRK trade ideas
$MRK key support and resistanceFirst key test will be at 75.42
Next, 73.02 and then 66.49
Price Target: 83.46, Final Price Target near all time high 92
MRK Long, 60M Demand ZoneThe Highlighted Area had been traded many times.
Buy orders and Sell orders had been filled by each other.
Once demand zone got confirmed,
This area will be treated as GAP.
Earning will not affect this trade.
Entry: 74.5 (Below 75)
Stop: 72.8; Below Demand zone
Target: 82; risk/reward=1:4
This is a trading school homework. I need few months to practice trading plan.
If you like it, thank you for your support. Please use SIM/Demo account to try it, until my trading plans get high winning rate.
Merck & CO $MRKAfter hitting 100SMA, it went down and seems that found its support which worked several times before. It may attract the buyers again
12 months Consensus Price Target: $94.21
if you find my charts useful, please leave me "like" or "comment".
Please don't trade according to the ideas, rely on your own knowledge.
Thx
Merck has upside to $82Analyst forecasts for Merck earnings came down sharply early this year, but lately they've stabilized and even ticked upward a little. Merck is still priced for an optimistic market, with forward P/E around 15 and PEG around 2-3. This is reasonable for a large cap company with 3% dividend and a great reputation, but it's not bargain pricing, exactly. A second round of lockdowns or a second wave of Covid-19 could hurt the stock again.
But as long there's no major deterioration of the macroeconomic outlook, the fair value range for Merck is about $75-82 per share. Analysts have been slow to make any forecasts for 2022 due to macroeconomic uncertainty, but I predict that the top end of the fair value range will shift upward to $87 per share once the 2022 forecasts finally come in.
Merck is oversold today on the hourly RSI and curling upward. MACD is below the signal line, but also curling upward. A few minutes ago Merck announced an FDA approval to expand the label for GARDASIL, its HPV drug. I suspect this may function as a catalyst to send Merck back upward toward $82 per share. I bought some shares after-hours, and if I can get in cheap enough, I will consider some call options tomorrow with maybe a one-month expiration.
Merck & Company Inc (MRK - NYSE) - Impulse wave upMerck & Company Inc (MRK - NYSE) is in internal 3rd of 3rd wave up (or C wave - in any case it will direct upside). It is about to complete 1st minor wave of 3rd internal wave after which only entry will be possible. But watch the invalidation level closely to maintain stops.
Merck Going All the Way UPAfter bottoming out last month, Merck has always had some tough time passing over $90 for the last couple of year. Well seem like the time is need and even breaking $100 is possible.
Mrk forming a cupMRK is forming a cup and is heading up. It just finished recent downtrend do to it's was overbought. It could go up to $85 area. It also hit the support. MRK is neither overbought not oversold.
Concave illustrate of MRK......!!!Concave describes an inward curve; its opposite, convex, describes a curve that bulges outward. They are used to describe gentle, subtle curves, like the kinds found in mirrors or lenses.
A graph is said to be concave up at a point if the tangent line to the graph at that point lies below the graph in the vicinity of the point and concave down at a point if the tangent line lies above the graph in the vicinity of the point.
A point where the concavity changes (from up to down or down to up) is called a point of inflection (POI).
